[1]吴春华.幽门螺杆菌感染的IgA肾病患者肾脏病理变化观察[J].中国实用乡村医生杂志,2019,26(12):57-59.[doi:10.3969/j.issn.1672-7185.2019.12.019 ]
 WU Chunhua.Kidney Pathological Changes in IgA Nephropathy Patients Infected by Helicobacter Pylori[J].Chinese Practical Journal of Rural Doctor,2019,26(12):57-59.[doi:10.3969/j.issn.1672-7185.2019.12.019 ]
点击复制

幽门螺杆菌感染的IgA肾病患者肾脏病理变化观察()
分享到:

《中国实用乡村医生杂志》[ISSN:1672-7185/CN:21-1502/R]

卷:
26
期数:
2019年12期
页码:
57-59
栏目:
论著
出版日期:
2019-12-15

文章信息/Info

Title:
Kidney Pathological Changes in IgA Nephropathy Patients Infected by Helicobacter Pylori
文章编号:
 1672-7185(2019)12-0057-03 
作者:
吴春华
作者单位:112300 辽宁 开原,开原市中医医院病理科
Author(s):
WU Chunhua
(Department of Pathology, Kaiyuan Hospital of Traditional Chinese Medicine, Kaiyuan 112300, Liaoning Province, China)
关键词:
 IgA肾病幽门螺杆菌感染病理变化
Keywords:
IgA Nephropathy Helicobacter Pylori Infection Pathology Change
分类号:
 R692.31 
DOI:
10.3969/j.issn.1672-7185.2019.12.019
文献标志码:
 A
摘要:
 目的 探讨幽门螺杆菌( H P)感染后I gA肾病患者肾脏病理组织改变。方法 收集开原市中医医院2017—2019年接诊的IgA肾病患者79例,依据是否出现HP感染分为感染组36例和非感染组43例;采用Katafuchi半定量评分法对肾脏病理切片进行评分。结果 感染组肾小球增殖程度、节段损害、球性硬化、肾小管间质积分、血管积分及总分均高于非感染组,差异均有统计学意义(P<0.05)。结论 HP感染可进一步加重IgA肾病病情进展,从肾脏病理学来看组织损伤进一步加重。
Abstract:
Objective To investigate the renal pathological changes in patients with IgA nephropathy after Helicobacter pylori (HP) infection. Methods A total of 79 patients with IgA nephropathy who were admitted to our hospital from 2017 to 2019 were divided into infection group (36 cases) and non-infection group (43 cases) according to whether HP infection occurred. Kidney pathological sections were scored by Katafuchi semi-quantitative scoring method. Results The glomerular proliferation, segmental damage, glomerular sclerosis, tubulointerstitial score, vascular score and total score in the infected group were significantly higher than those in the non-infected group (P<0.05). Conclusion HP infection can further aggravate the progression of IgA nephropathy and further aggravate the tissue damage in terms of renal pathology.

参考文献/References:

[1] 张永哲,刘大军,李德天.幽门螺杆菌与I g AN、MN、H S P N、DN相关性研究进展[ J ].医学综述,2018,24(13):2621-2626.
[2]王妮妮,姜芝红.奥美拉唑、左氧氟沙星、阿莫西林三联疗法根除消化性溃疡患者幽门螺杆菌的疗效观察[J].中国保健营养,2019,29(13):351.
[3] 马雅霞,杜学芹,雒芳玲,等.幽门螺杆菌感染与免疫相关性疾病的研究进展[ J].医学综述,2018,24(21):4235-4239,4244.
[4] 王振伟,杨帅帅.幽门螺杆菌感染与IgA肾病关系的研究进展[J].中国当代医药,2013,20(18):23-24.
[5] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:485-487.
[6] 杨青梅,鲍晓荣.幽门螺杆菌感染与IgA肾病的关系[J].临床肾脏病杂志,2012,12(9):413-415.
[7] 赵彦.慢性胃炎胃镜下不同病理改变与幽门螺杆菌感染的分析[J].饮食保健,2019,6(28):44-45.
[8] 吴赛青,程平,邢学伟,等.肾穿刺组织冷冻切片常见问题及对策[J].临床与实验病理学杂志,2018,34(5):576-577.
[9] 赵庆雨.I gA肾病患者I gM沉积表达与尿蛋白和肾脏病理变化的关系[J].医学临床研究,2018,35(9):1709­1711,1714.
[10] 勾筱娟,郭宏艳,赵颖,等.肾康注射液对I gA肾病尿蛋白及肾功能的影响[ J ].中国老年学杂志,2019,39(12):2964-2966.
[11] 焦冬菊,孙轸,谢佳平.幽门螺杆菌感染检测方法的研究进展[J].检验医学与临床,2018,15(17): 2667­2669.
[12] 张双双,张喆,冯义朝.根除幽门螺杆菌对逆转胃癌前病变的研究进展[J].临床医学进展,2018,8(8): 673­678.
[13] 刘恋,杨清.幽门螺杆菌感染与治疗的研究进展[J].山东化工,2019,48(4):55,58.
[14] 李俊,沈颖.影响IgA肾病预后因素研究进展[J].中国社区医师,2017,33(1):8-9.
[15] 杨青梅,鲍晓荣.幽门螺杆菌及IL-17高表达与原发性IgA肾病的关系[J].临床内科杂志,2013,30(2):95­97.

相似文献/References:

[1]郁砚辉.幸运飞艇最新的效果评价[J].中国实用乡村医生杂志,2019,26(01):53.[doi:10.3969/j.issn.1672-7185.2019.01.023]
 YU Yanhui.Evaluation of Danshen Injection in Adjuvant Treatment of Helicobacter Pylori-Positive Gastric Ulcer[J].Chinese Practical Journal of Rural Doctor,2019,26(12):53.[doi:10.3969/j.issn.1672-7185.2019.01.023]

备注/Memo

备注/Memo:
收稿日期:2019-07-22)

更新日期/Last Update: 2019-12-31